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Comments on Extrapolation of Cancer
Response from High Dose to Low Dose
by Norton Nelson*
In making judgments as to the cancer risk from low level exposure to carcinogens it is generally
necessary to base thesejudgments on high dose or high incidence data from laboratory or epidemiological
studies. The biological considerations involved in making such extrapolations are discussed, as well as
some of the mathematical procedures. The difficulties presented by moving from species to species, or
from differently actingcarcinogenic agents is considered.
Prediction from high cancer incidence in humans
or laboratory animals to the lower levels possibly
associated with community air pollution is difficult.
At the present time, it seems that projections from
human epidemiological data are more reliable, un-
certain though they may be, than are projections
from laboratory animals.
The art of quantitative evaluation of car-
cinogenicity in laboratory animals has progressed
immensely in the past twenty years. It seems
reasonably reliable in simple situations, but uncer-
tain in more complex circumstances.
If one makes the assumption that intrinsic tissue
sensitivity is reasonably uniform from species to
species (there are exceptions), dosage can be com-
puted on a rational basis moving between species,
and from higher and lower doses, especially where
the tumors are produced in the exposed tissue by
direct-acting carcinogens.
With high dose, direct-acting agents, e.g., ioniz-
ing radiation or alkylating chemicals, confidence in
quantitative inferences is highest. Thus in the direct
production of skin cancer from ionizing radiation
(1), or from inhaled alkylating agents, e.g.,
bis(chloromethyl)ether (2), one is dealing with di-
rect dosage of the responsive tissue. Also, promot-
ing or cocarcinogenic factors are probably of less
importance in the high dose-response range. On the
other hand, it is perfectly clear that even with ioniz-
ing radiation, coacting factors can be of decisive
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importance. Thus, doses of ionizing radiation pro-
ducing a significant response ofbreast cancer in rats
(3), or leukemia in AKR mice (4), are considerably
lower than those producing epithelial cancer in
skin. Are viral or hormonal factors responsible for
the greater radiation sensitivity? It seems very pos-
sible that they are. It is also clear that cigarette
smoking is a powerful synergistic factor in the pro-
duction oflung cancer in uranium miners (5).
When one moves from direct-acting chemical
agents to those that require activation, such as ar-
omatic amines (l8-naphthylamine and benzidine) or
the hydrocarbons (benzo[a]pyrene), the situation
becomes much more uncertain.
These additional variables enter the equation
when there are species differences in activating and
inactivating enzymes. We know very well that these
species variations can in some cases be substantial.
Thus, 8-naphthylamine produces bladder cancer in
the dog and in hamsters to a lesser extent, while
other species are essentially nonresponsive to blad-
der cancer from this agent. Analysis of the situa-
tion, where the activation of the carcinogen occurs
in the tissue or cell where the tumors are produced,
e.g., skin painting with benzo[a]pyrene, is simpler
than where the activation occurs in one organ and
the tumors are produced in another. In the latter
case, confidence in the projections must necessarily
be additionally weakened.
It seems highly probable that in most real-life
human cancer, modulating factors, cocarcinogens,
and promoting agents, play very important roles.
Certainly there is every reason tobelieve that this is
true oflung cancer.
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yield from benzo[a]pyrene goes up with local injury
and procedures which enhance persistence (pellet
or thread implant), and with irritants such as sulfur
dioxide and nitrogen dioxide (6). In the case of air
pollution there is reason to believe that smoking
intensifies the response to air pollution (7).
The use of laboratory animal models for esti-
mates ofresponse which are meaningful for humans
is thus, no doubt useful in some of the simpler situ-
ations but becomes progressively less reliable as the
steps involved increase in complexity, i.e., one
species to another; agents requiring activation; ac-
tivation in one organ, tumors in another; and major
influence of stimulatory or inhibitory coacting en-
zymes or agents. Accordingly, laboratory studies
are of great utility for yes or no answers, for direct
comparison of agents within the same family of
compounds, for comparison of the influence of
selected stimulatory or inhibitory factors on the
same agent, but inspire less confidence as the situa-
tion grows more complex.
The forms of the curves relating cancer response
to dose have received much attention and one can
find in the literature examples to support almost any
postulated pattern. Breast cancer in the rat from
ionizing radiation starts well above zero and is sub-
stantially linear (3); lung cancer in the rat, with
ionizing radiation, probably approximates linearity
at low doses but is concave upward in the higher
dose ranges (8). A similar pattern is found with
chemical carcinogens in the rat with regard to lung
cancer (8). Leukemia arising from radiation of pa-
tients with spondylitis shows concavity upward
over a broad dose range but essential linearity at
low dose spans (9).
Such curves exhibit, at first glance, a quasi-
threshold; closer inspection usually shows them to
be lines with lower slope starting from the origin
and then moving exponentially up. There is no
reason to believe that carcinogens which show
thresholds will not eventually be identified. It
seems logical to assume that, where detoxifying
processes (enzymatic or nonenzymatic) are fiinc-
tioning, very low levels of some agents will be inac-
tivated before they reach the biochemical element
of the cell (DNA) required for the production of
malignancy. However, at this time I am unaware of
any well documented demonstration of such a
threshold.
Numerous dose-response models varying so-
phistication have been devised. This is a field now
receiving far more attention than it has in the past.
Some of these models are extrapolation systems,
which, by the incorporation ofsafety factors, aim at
conservatism. These cannot be regarded as an un-
biased, or "most plausible" analysis of response to
dose. The Mantel/Bryan procedure is an example of
this which, by choice of slope, automatically incor-
porates a safety factor (10). A procedure which at-
tempts a "most plausible" estimate has been de-
scribed by Albert and Altshuler (11). This incorpo-
rates a time-to-tumor-occurrence component, as
well as incidence or frequency of tumors. Any rel-
evant model must take into account time to occur-
rence, since there is clear evidence that with higher
dose, tumors occur earlier than with lower doses.
The practical application ofsuch models at this time
is very restricted, since the basic data are rarely
available. Albert and Altshuler, however, have
shown that the model fits a number of patterns of
cancer occurrence in animals exposed to chemical
carcinogens and ionizing radiation, and have also
shown that it fits the lung cancer-cigarette smoking
relationship in humans.
In summary, it appears that at the present time
the most confident estimation of the quantitative
impact of air pollution on human cancer will come
from epidemiological data which in some instances
will be reinforced by laboratory data on animals.
REFERENCES
I. Albert, R. E., Burns, F. J., and Bennett, P. Radiation in-
duced hair follicle damage and tumor formation in mouse
and rat skin. J. Natl. Cancer Inst. 49: 1131 (1972).
2. Kuschner, M., et al. Inhalation carcinogenicity ofalpha halo
ethers, Ill. Lifetime and limited period inhalation studies
with bis(chloromethyl)ether at 0.1 ppm. Arch. Environ.
Health 30: 73 (1975).
3. Shellabarger, C. J., et al. Results of fractionation and pro-
traction of total body radiation on rat mammary neoplasia.
Cancer Res. 26: 509 (1966).
4. Upton, A. C., et al. Observations on viral chemical and
radiation-induced myeloid and lymphoid leukemia in RF
mice. In: Conference on Murine Leukemia (National
Cancer Institute Monograph 22) U. S. Department of
Health, Education and Welfare, Public Health Service, Na-
tional Cancer Institute, Bethesda, Md., 1966, pp. 329-347.
5. Saccomonno, G. Uranium miners health. In: Radiation
Standards for Uranium Mining. Hearings before the Sub-
committee on Research,Development, and Radiation ofthe
Joint Committee on Atomic Energy. Congress ofthe United
States, Ninety-first Congress, First Session, March 17 and
18, 1969. U. S. Government Printing Office, Washington,
D. C., pp. 301-315.
6. Laskin, S., et al. Combined carcinogen-irritant animal inha-
lation studies. In: Air Pollution and the Lung, E. F.
Aharonson, A. Ben-David, and M. A. Klingbert, Eds.,
Wiley, New York, 1976, pp. 190-213.
7. Air pollution and cancer. Risk assessment methodology and
epidemiological evidence. Report from an international
symposium at the Karolinska Institute. Environ. Health
Perspect., 22: 1 (1978).
8. Kuschner, M. The causes of lung cancer. Amer. Rev. Resp.
Dis. 98: 573 (1968).
94 Environmental Health Perspectives9. Court Brown, W. M., andDoll, R. Leukemia and Aplastic
Anemia in Patients Irradiated for Ankylosing Spondylitis.
Medical Research Council Special Report, No. 295, Lon-
don, 1957.
10. Mantel, N., and Bryan, W. R. "Safety" testing of car-
cinogenic agents. J. Natl. Cancer Inst. 27: 455 (1961).
11. Albert, R. E., and Altshuler, B. Considerations relating to
the formulation of limits for unavoidable population expo-
sures to environmental carcinogens. In: Radionuclide Car-
cinogenesis, C. L. Sander, R. H. Busch, and J. E. Ballou,
Eds., U. S. Atomic Energy Commission, CONF-720505,
NTIS, Springfield, Va., 1973, pp. 233-253.
February 1978 95